Belpointe Asset Management LLC Has $225,000 Stake in Hims & Hers Health, Inc. $HIMS

Key Points

• Belpointe Asset Management LLC significantly reduced its stake in Hims & Hers Health, dropping ownership by 49.6% to hold 7,623 shares valued at $225,000.
• Hims & Hers Health's stock has recently faced challenges, falling by 2.7% and posting an EPS of $0.17, below the consensus estimate.
• Major institutional investors increased their holdings in Hims & Hers Health, with notable increases including 128.5% from GAMMA Investing LLC and 95.2% from New York State Teachers Retirement System.

Belpointe Asset Management LLC lessened its holdings in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 49.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,623 shares of the company's stock after selling 7,514 shares during the period. Belpointe Asset Management LLC's holdings in Hims & Hers Health were worth $225,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Intech Investment Management LLC increased its stake in shares of Hims & Hers Health by 74.5% during the 1st quarter. Intech Investment Management LLC now owns 143,287 shares of the company's stock worth $4,234,000 after purchasing an additional 61,195 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Hims & Hers Health by 23.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 418,699 shares of the company's stock valued at $12,373,000 after purchasing an additional 78,543 shares during the last quarter. Arete Wealth Advisors LLC acquired a new position in Hims & Hers Health in the 1st quarter valued at approximately $300,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Hims & Hers Health by 3.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 211,480 shares of the company's stock valued at $6,249,000 after purchasing an additional 6,876 shares during the period. Finally, Bosun Asset Management LLC bought a new position in Hims & Hers Health during the 1st quarter valued at about $272,000. 63.52% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Needham & Company LLC reiterated a "hold" rating on shares of Hims & Hers Health in a report on Tuesday, August 5th. Zacks Research cut Hims & Hers Health from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 19th. Morgan Stanley restated an "equal weight" rating and set a $40.00 price target on shares of Hims & Hers Health in a report on Wednesday, June 11th. Truist Financial reduced their target price on Hims & Hers Health from $48.00 to $37.00 and set a "hold" rating on the stock in a research report on Monday, August 18th. Finally, Citigroup reissued a "sell" rating on shares of Hims & Hers Health in a report on Monday, June 23rd. Two research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Reduce" and a consensus target price of $38.92.

Hims & Hers Health Price Performance

NYSE:HIMS traded up $1.54 during mid-day trading on Friday, hitting $57.74. The company's stock had a trading volume of 36,152,647 shares, compared to its average volume of 27,039,632. The company has a current ratio of 4.98, a quick ratio of 4.46 and a debt-to-equity ratio of 1.72. The company has a market capitalization of $13.05 billion, a price-to-earnings ratio of 72.18, a P/E/G ratio of 3.80 and a beta of 2.14. Hims & Hers Health, Inc. has a fifty-two week low of $15.73 and a fifty-two week high of $72.98. The stock has a fifty day moving average of $50.71 and a 200-day moving average of $45.66.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%.The firm had revenue of $544.83 million during the quarter, compared to analyst estimates of $550.06 million. During the same quarter last year, the business posted $0.06 earnings per share. The company's revenue for the quarter was up 72.6% on a year-over-year basis. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities analysts forecast that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Insider Transactions at Hims & Hers Health

In other news, CFO Oluyemi Okupe sold 145,000 shares of the firm's stock in a transaction that occurred on Monday, September 15th. The shares were sold at an average price of $55.35, for a total value of $8,025,750.00. Following the completion of the transaction, the chief financial officer directly owned 128,984 shares in the company, valued at approximately $7,139,264.40. This trade represents a 52.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Patrick Harrison Carroll sold 60,000 shares of Hims & Hers Health stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $53.58, for a total transaction of $3,214,800.00. Following the completion of the transaction, the insider directly owned 169,940 shares in the company, valued at approximately $9,105,385.20. The trade was a 26.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,535,085 shares of company stock valued at $78,035,921 in the last 90 days. 13.71% of the stock is currently owned by corporate insiders.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.